메뉴 건너뛰기




Volumn 147, Issue 32, 2003, Pages 1537-1538

Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: Some brief comments;Hart- en vaatziekte bij 55-plussers bestrijden met een combinatiepil tegen 4 risicofactoren; kanttekeningen

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GENERIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

EID: 0042832707     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (5)
  • 1
    • 0038165393 scopus 로고    scopus 로고
    • A strategy to reduce cardiovascular disease by more than 80%
    • Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
    • (2003) BMJ , vol.326 , pp. 1419
    • Wald, N.J.1    Law, M.R.2
  • 2
    • 0037193819 scopus 로고    scopus 로고
    • Risk factor thresholds: Their existence under scrutiny
    • Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002;324:1570-6.
    • (2002) BMJ , vol.324 , pp. 1570-1576
    • Law, M.R.1    Wald, N.J.2
  • 3
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 4
    • 0001132313 scopus 로고    scopus 로고
    • European action on secondary prevention by intervention to reduce events. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries
    • EUROASPIRE I and II Group. European action on secondary prevention by intervention to reduce events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001.
    • (2001) Lancet , vol.357 , pp. 995-1001
  • 5
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.